1
E not available for all women. Furthermore the numbers of women in early menopause were few. These complications of data led us to the crude analysis used in the study. However, our analysis was good enough to show the variability between women, and suggest the need for larger follow-up studies to describe the natural course of menopausal symptoms. To estimate the duration of symptoms among unsele
1
En 19?4.Our sample size was too small to analyze this in relation to background characteristics to explain the variation. The results of the longitudinal analysis (comparing the same women over time) and those of the cross-sectional analysis showed relatively similar results. Thus, we can interpret the cross-sectional data as generally summing up the experience of all women throughout the followup
1
Omen with bothersome symptoms first increased and then decreased. Conclusions: There was a notable variability in the development of disturbing vasomotor symptoms over time in a selected group of women aged 50?9. Population-based follow-up studies of untreated women would be useful to estimate the symptom burden. Keywords: Menopausal symptoms, Duration, Follow-up, EstoniaBackground A number of stu
1
Ited by Eaton P. New York: Nova Publishers; 2001. 11. Piliang K: Indonesia arrests 8 in fires causing choking haze. http://www. irrawaddy.org/asia/indonesia-arrests-8-in-fires-causing-choking-haze.html. 12. Schiffman SS: Introduction: health and ecological linkages. Environ Int 2003, 29:351. 13. Gadit AAM: Ecology and mental health: time to understand ecopsychiatry. J Pakistan Med Assoc 2009, 59:5
1
T least one of these symptoms was said to be bothersome,Hemminki et al. BMC Women's Health 2012, 12:44 http://www.biomedcentral.com/1472-6874/12/Page 3 ofthe woman was categorized as having bothersome symptoms of that group.Table 2 Proportions ( ) of women with vasomotor symptoms and bothersome symptoms1 in past two weeks, at each survey (cross-sectional analysis)Recruitment Women
1
Ps were very similar by the studied background characteristics. Table 2 gives the prevalence of vasomotor symptoms according to a cross-sectional analysis. At the time of recruitment, about two thirds of the women reported vasomotor symptoms, and about a half regarded them as bothersome. In the survey a year later, less (53 ) of women reported vasomotor symptoms and a third found them bothersome.
1
Ps were very similar by the studied background characteristics. Table 2 gives the prevalence of vasomotor symptoms according to a cross-sectional analysis. At the time of recruitment, about two thirds of the women reported vasomotor symptoms, and about a half regarded them as bothersome. In the survey a year later, less (53 ) of women reported vasomotor symptoms and a third found them bothersome.
1
E therapy to either placebo or nothing (the control groups) [21]. Women were recruited in Estonia from 1999?001, and followed by annually mailed questionnaires in 2000?004. Detailed descriptions of the recruitment, inclusion and exclusion criteria, trial treatment, adherence, follow-up and trial outcomes as well as the content of information leaflets and trial questionnaires have been published el